Zhejiang Starry PharmaceuticalLtd Future Growth
Future criteria checks 5/6
Zhejiang Starry PharmaceuticalLtd is forecast to grow earnings and revenue by 88.7% and 22.8% per annum respectively. EPS is expected to grow by 88.1% per annum. Return on equity is forecast to be 13% in 3 years.
Key information
88.7%
Earnings growth rate
88.1%
EPS growth rate
| Pharmaceuticals earnings growth | 18.3% |
| Revenue growth rate | 22.8% |
| Future return on equity | 13.0% |
| Analyst coverage | Low |
| Last updated | 05 Sep 2024 |
Recent future growth updates
Recent updates
There's No Escaping Zhejiang Starry Pharmaceutical Co.,Ltd.'s (SHSE:603520) Muted Revenues
Sep 30
Shareholders Can Be Confident That Zhejiang Starry PharmaceuticalLtd's (SHSE:603520) Earnings Are High Quality
May 06Market Might Still Lack Some Conviction On Zhejiang Starry Pharmaceutical Co.,Ltd. (SHSE:603520) Even After 31% Share Price Boost
Mar 12Is Zhejiang Starry PharmaceuticalLtd (SHSE:603520) Using Too Much Debt?
Feb 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3,985 | 467 | N/A | 645 | 3 |
| 12/31/2025 | 3,240 | 288 | N/A | 597 | 3 |
| 12/31/2024 | 2,633 | 108 | N/A | 442 | 3 |
| 9/30/2024 | 2,370 | 14 | -353 | -13 | N/A |
| 6/30/2024 | 2,443 | 32 | -148 | 106 | N/A |
| 3/31/2024 | 2,272 | 47 | -104 | 179 | N/A |
| 12/31/2023 | 2,196 | 44 | -222 | 45 | N/A |
| 9/30/2023 | 2,385 | -56 | -167 | 113 | N/A |
| 6/30/2023 | 2,273 | -105 | -289 | 61 | N/A |
| 3/31/2023 | 2,180 | -147 | -444 | -27 | N/A |
| 12/31/2022 | 2,131 | -76 | -551 | -78 | N/A |
| 9/30/2022 | 2,066 | 124 | -427 | 143 | N/A |
| 6/30/2022 | 2,087 | 232 | -334 | 176 | N/A |
| 3/31/2022 | 2,153 | 339 | 33 | 427 | N/A |
| 12/31/2021 | 2,000 | 324 | 205 | 509 | N/A |
| 9/30/2021 | 1,631 | 260 | 149 | 303 | N/A |
| 6/30/2021 | 1,500 | 255 | 65 | 233 | N/A |
| 3/31/2021 | 1,440 | 258 | -8 | 152 | N/A |
| 12/31/2020 | 1,367 | 239 | 21 | 174 | N/A |
| 9/30/2020 | 1,370 | 231 | 31 | 190 | N/A |
| 6/30/2020 | 1,395 | 217 | 95 | 262 | N/A |
| 3/31/2020 | 1,306 | 175 | 84 | 242 | N/A |
| 12/31/2019 | 1,309 | 170 | 113 | 247 | N/A |
| 9/30/2019 | 1,242 | 146 | 72 | 208 | N/A |
| 6/30/2019 | 1,098 | 122 | 24 | 138 | N/A |
| 3/31/2019 | 988 | 112 | 66 | 209 | N/A |
| 12/31/2018 | 890 | 94 | 29 | 192 | N/A |
| 9/30/2018 | 794 | 98 | -5 | 134 | N/A |
| 6/30/2018 | 742 | 94 | N/A | 170 | N/A |
| 3/31/2018 | 712 | 77 | N/A | 69 | N/A |
| 12/31/2017 | 711 | 83 | N/A | 32 | N/A |
| 9/30/2017 | 712 | 84 | N/A | 35 | N/A |
| 6/30/2017 | 712 | 84 | N/A | -22 | N/A |
| 3/31/2017 | 698 | 79 | N/A | -4 | N/A |
| 12/31/2016 | 673 | 76 | N/A | 8 | N/A |
| 9/30/2016 | 716 | 81 | N/A | 34 | N/A |
| 6/30/2016 | 691 | 74 | N/A | 76 | N/A |
| 3/31/2016 | 661 | 60 | N/A | 37 | N/A |
| 12/31/2015 | 696 | 69 | N/A | 95 | N/A |
| 12/31/2014 | 658 | 68 | N/A | 144 | N/A |
| 12/31/2013 | 686 | 64 | N/A | 75 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603520's forecast earnings growth (88.7% per year) is above the savings rate (2.8%).
Earnings vs Market: 603520's earnings (88.7% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 603520's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 603520's revenue (22.8% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 603520's revenue (22.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 603520's Return on Equity is forecast to be low in 3 years time (13%).